Biologists investigating how soil bacteria degrade a new generation of plant-based bioplastics have identified an enzyme that can break down both plastic polymers and antibiotic molecules. The discovery emerged from research into long-chain aliphatic polyesters, materials increasingly used as biodegradable alternatives to conventional petroleum-based plastics.
The enzyme, produced by soil-dwelling bacteria, was found to cleave the chemical bonds in these bioplastic chains. During laboratory characterization, the research team observed that the same catalytic activity also dismantled certain antibiotic compounds. This dual functionality places the enzyme at an unusual intersection of two pressing environmental concerns: the accumulation of plastic waste and the spread of antibiotic residues in soil and water systems.
Long-chain aliphatic polyesters represent a promising class of bioplastics derived from renewable plant sources. They are designed to be compostable and environmentally benign, yet their actual degradation rates in natural settings depend heavily on the presence of microorganisms equipped with the right enzymatic machinery. Understanding precisely which bacterial enzymes perform this work is essential for predicting how these materials behave once discarded, and for engineering more efficient degradation pathways.
The newly described enzyme adds to a growing catalog of microbial tools that break down synthetic and semi-synthetic polymers. Its additional activity against antibiotics is particularly notable because antibiotic contamination in the environment is a recognized driver of antimicrobial resistance. When antibiotics persist in soils and waterways, they exert selective pressure on microbial communities, encouraging the survival and spread of resistant strains. Enzymes that degrade these compounds could, in principle, help mitigate that pressure, though the researchers caution that much work remains before any practical application could be developed.
The study's findings also raise questions about the natural ecological roles of such enzymes. Bacteria did not evolve these proteins specifically to address human plastic pollution; their primary functions are almost certainly related to microbial metabolism and competition in soil environments. The ability to break down bioplastic polymers may be a fortuitous side effect of an enzyme that originally targeted other natural compounds, including molecules that resemble parts of antibiotic structures.
This overlap between plastic degradation and antibiotic degradation highlights the chemical similarities that can exist between seemingly unrelated classes of molecules. Both bioplastics and many antibiotics are built from repeating units linked by ester or amide bonds, bonds that hydrolytic enzymes can readily target. The discovery underscores how basic research into microbial biochemistry can yield insights relevant to multiple applied problems at once.
The research team plans to continue characterizing the enzyme's structure, substrate specificity, and reaction kinetics. Future work will examine whether the enzyme can be optimized for industrial use, either in waste treatment facilities designed to process biodegradable plastics or in bioremediation strategies aimed at reducing antibiotic loads in contaminated environments. Any such deployment would require careful study of the enzyme's stability, efficiency, and safety under real-world conditions.
The findings contribute to a broader understanding of the microbial capacity to transform human-made and naturally occurring organic compounds. As bioplastics gain market share and antibiotic pollution remains a global concern, enzymes with dual degradative abilities may become increasingly valuable tools for environmental management.
